Found: 12
Select item for more details and to access through your institution.
Randomized, double-blind clinical trial comparing basal insulin peglispro and insulin glargine, in combination with prandial insulin lispro, in patients with type 1 diabetes: IMAGINE 3.
- Published in:
- Diabetes, Obesity & Metabolism, 2016, v. 18, n. 11, p. 1081, doi. 10.1111/dom.12698
- By:
- Publication type:
- Article
Glycaemic control and hypoglycaemia with new insulin glargine 300 U/ml versus insulin glargine 100 U/ml in people with type 2 diabetes using basal insulin and oral antihyperglycaemic drugs: the EDITION 2 randomized 12-month trial including 6-month extension
- Published in:
- Diabetes, Obesity & Metabolism, 2015, v. 17, n. 12, p. 1142, doi. 10.1111/dom.12532
- By:
- Publication type:
- Article
LEADER 2: baseline calcitonin in 9340 people with type 2 diabetes enrolled in the Liraglutide Effect and Action in Diabetes: Evaluation of cardiovascular outcome Results ( LEADER) trial: preliminary observations.
- Published in:
- Diabetes, Obesity & Metabolism, 2015, v. 17, n. 5, p. 477, doi. 10.1111/dom.12444
- By:
- Publication type:
- Article
New insulin glargine 300 U/ml compared with glargine 100 U/ml in insulin-naïve people with type 2 diabetes on oral glucose-lowering drugs: a randomized controlled trial (EDITION 3).
- Published in:
- Diabetes, Obesity & Metabolism, 2015, v. 17, n. 4, p. 386, doi. 10.1111/dom.12438
- By:
- Publication type:
- Article
Contrasting weight changes with LY2605541, a novel long-acting insulin, and insulin glargine despite similar improved glycaemic control in T1DM and T2DM.
- Published in:
- Diabetes, Obesity & Metabolism, 2014, v. 16, n. 4, p. 351, doi. 10.1111/dom.12223
- By:
- Publication type:
- Article
Exenatide once weekly improved glycaemic control, cardiometabolic risk factors and a composite index of an HbA1c < 7%, without weight gain or hypoglycaemia, over 52 weeks.
- Published in:
- Diabetes, Obesity & Metabolism, 2013, v. 15, n. 3, p. 264, doi. 10.1111/dom.12026
- By:
- Publication type:
- Article
Metabolic outcomes of matched patient populations initiating exenatide BID vs. insulin glargine in an ambulatory care setting.
- Published in:
- Diabetes, Obesity & Metabolism, 2012, v. 14, n. 7, p. 626, doi. 10.1111/j.1463-1326.2012.01581.x
- By:
- Publication type:
- Article
Observations on C-peptide and free insulin in the blood during continuous subcutaneous insulin infusion and conventional insulin therapy.
- Published in:
- 1985
- By:
- Publication type:
- journal article
Observations on control of glycemia with conventional insulin therapy or continuous subcutaneous insulin infusion.
- Published in:
- 1985
- By:
- Publication type:
- journal article
Glucose counterregulation in patients after pancreatectomy. Comparison with other clinical forms of diabetes.
- Published in:
- 1984
- By:
- Publication type:
- journal article
Lack of glucagon response to hypoglycemia in type I diabetics after long-term optimal therapy with a continuous subcutaneous insulin infusion pump.
- Published in:
- 1983
- By:
- Publication type:
- journal article
Use of an automated device for alternative site blood glucose monitoring.
- Published in:
- 2001
- By:
- Publication type:
- journal article